MUMBAI, India, Dec. 13 -- Intellectual Property India has published a patent application (202511101893 A) filed by Indian Institute Of Technology, Mandi, Himachal Pradesh, on Oct. 23, for 'needle-free high-pressure injector arrangement for adaptive insulin delivery and a device thereof.'
Inventor(s) include Dr. Tirthankar Deb; Dr. Dipankar Deb; Dr. Shampa Maji; and Dr. Krishnasish Das.
The application for the patent was published on Dec. 12, under issue no. 50/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to an AI algorithm-guided needle-free injector system (100) for real-time insulin delivery. The system includes a detachable sensor unit (110) with a non-invasive glucose sensor (112) and a pressure or skin thickness sensor (114). A processor (120) processes glucose and tissue resistance data to calculate a personalized insulin dose and injection parameters. A high-pressure injection system (140) draws insulin from a reservoir (142) and delivers it through a nozzle (144) without use of a needle. A digital display screen (130) presents real-time dose information and history, while a safety control unit (180) prevents overdose or underdose. An alarm system (170) detects spillage or incomplete delivery and generates alerts (172, 174). A wireless communication interface (160) connects the system to a mobile application (102) for logging, reminders, and clinician monitoring. The system ensures non-invasive, personalized, and safe insulin delivery with improved adherence and usability."
Disclaimer: Curated by HT Syndication.
